Cargando…
Androgen receptor expression in metastatic adenocarcinoma in females favors a breast primary
BACKGROUND: The differential diagnosis of metastatic mammary adenocarcinoma and adenocarcinomas from other primary sites can be challenging, particularly in tumors that are poorly differentiated and negative for Estrogen/Progesterone receptors (ER/PR). With progression of disease, Androgen receptors...
Autores principales: | Shidham, Vinod B, Komorowski, Richard A, Machhi, Jinobya K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1601970/ https://www.ncbi.nlm.nih.gov/pubmed/17020615 http://dx.doi.org/10.1186/1746-1596-1-34 |
Ejemplares similares
-
Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW Melanoma Cocktail' – A mixture of monoclonal antibodies to MART-1, melan-A, and tyrosinase
por: Shidham, Vinod B, et al.
Publicado: (2003) -
Two-color immunocytochemistry for evaluation of effusion fluids for metastatic adenocarcinoma
por: Shidham, Vinod B, et al.
Publicado: (2010) -
Androgen receptor expression identifies patient with favorable outcome in operable triple negative breast cancer
por: Hu, Xiao-Qing, et al.
Publicado: (2017) -
Metastatic Carcinoma in Effusions
por: Shidham, Vinod B.
Publicado: (2022) -
Androgen receptor expression on circulating tumor cells in metastatic breast cancer
por: Fujii, Takeo, et al.
Publicado: (2017)